The Hush Post| 9:27 am|one-minute-read|
Here are the top 10 stocks that should be in focus on Monday and keep a close watch on them.
Yes Bank: The private lender announced its September quarter earnings on Friday after market hours.
The bank reported a net loss of ₹600 crore for July-September due to adjustment of ₹709 crore in one-time deferred tax asset.
It had posted a net profit of ₹965 crore in the same period last year. The bank also aims to raise $1.2 billion equity capital by the end of December.
Maruti Suzuki: The country’s largest car-manufacturer remains ‘cautiously optimistic’ over sales prospect as many challenges that had led to a slowdown in the industry are still there. The company, whose domestic passenger vehicle sales grew after seven months in October, said it would take at least few more months to get clarity on the industry’s revival.
HDFC: The housing finance company will announce its September quarter earnings today. The company had last week acquired 9.89% stake in Bandhan Bank Ltd as part of the merger of the bank with HDFC Ltd’s subsidiary Gruh Finance Ltd. Separately, state-owned lender Indian Overseas Bank will also report its numbers for July-September today.
Vodafone Idea: India Ratings and Research downgraded non-convertible debentures of the telecom operator and placed them under negative watch citing adverse impact of the SC ruling on the definition of adjusted gross revenue. The ratings agency also noted increasing risk in bank loan payment defaults and delay in asset monetisation by the firm.
Thomas Cook: The travel services provider on Sunday clarified that the sale of the UK-based company to China’s Fosun does not include regions in India, Sri Lanka and Mauritius. The British travel group Thomas Cook PLC, which declared bankruptcy in September under piling debt, had sold its stake in Thomas Cook (India) Ltd in 2012 and is not related to the Indian firm.
Central Bank: The public-sector bank released its September quarter earnings after market hours on Friday. The bank posted a net profit of ₹138.6 crore for the second quarter due to enhancement in asset quality. The lender had reported a loss of ₹935.5 crore in the year-ago period. Apart from that, it also started taking approvals for raising equity capital by allotting preferential shares to the government.
Pharma Stocks: The US Food and Drug Administration late on Friday downplayed the risk associated with popular antacid medicine ranitidine, saying that the carcinogen N-nitrosodimethylamine is not formed after ingestion of the drug and that levels of the contaminant in most samples were similar to those found in common food.